MKI67 and neuroendocrine carcinoma: According to the 2019 WHO classification, GEP NENs are classified into well-differentiated neuroendocrine tumors (NETs) and poorly differentiated neuroendocrine carcinomas (NECs) based on both morphological features and proliferation rate (Ki-67 and/or mitotic index) (5).